AI assistant
DEXCOM INC — Director's Dealing 2023
May 22, 2023
30198_dirs_2023-05-22_31fd8aff-cefb-4b4c-b8ac-a4a525798feb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2023-05-18
Reporting Person: SKYLER JAY S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-18 | Common Stock | G | 3876 | $0.0 | Disposed | 0 | Direct |
| 2023-05-18 | Common Stock | G | 3876 | $0.0 | Acquired | 63348 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 40000 | Indirect |
Footnotes
F1: Shares were transferred from direct ownership to ownership under the Skyler Bach Family Limited Partnership, LLP, upon vesting of previously awarded restricted stock units.
F2: Shares are held by Skyler Bach Family Limited Partnership, LLP, with respect to which the reporting person is a managing partner of the partnership and maintains voting rights of these shares.
F3: The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.